Clinical Trial Update: Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

MP0533 is being studied in patients with acute myeloid leukemia or myelodysplastic syndrome in a Phase 1/2 trial that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• MP0533

Snippet

Sponsor: Molecular Partners AG | Conditions: Leukemia, Myeloid | Phase 1, Phase 2 | Status: RECRUITING